Nader Omidvar^1*, Stephanie Beurlet^2*, Carole Le Pogam^2*, Anne Janin³, Christophe Leboeuf^3*, Annie Soulie^2*, Niclas Setterblad^4*, Maria-Elena Noguera^5*, Laure Sarda-Mantel^6*, Pascal Merlet^6*, Marika Pla^2*, Scott C. Kogan, MD⁷, Irving L Weissman⁸, Marina Konopleva⁹, William Bormann^9*, Michael Andreeff⁹, Christine Chomienne² and Rose Ann Padua¹

¹Institut Universitaire d'Hématologie, Inserm U718, Paris, France & Cardiff University, Cardiff, United Kingdom
²Inserm U718, Institut Universitaire d'Hématologie, Paris, France
³Inserm U728, Institut Universitaire d'Hématologie, Paris, France
⁴Departement d'Imagerie, Hopital Saint-Louis, Paris, France
⁵Departement d'Hématologie, Hopital Saint-Louis, Paris, France
⁶Inserm U773, Hôpital Bichat, Paris, France
⁷Department of Laboratory Medicine, Helen Diller Family Comprehensive Cancer Center, University of California - San Francisco, San Francisco, CA
⁸Stanford University, CA
⁹M.D. Anderson Cancer Center, TX

Michael Kirwan^1*, Tom Vulliamy^1*, Amanda J. Walne^1*, Richard Beswick^1*, Peter Hillmen², Richard Kelly^2*, Andrew Stewart^3*, David Bowen^2*, Stefan Schonland^4*, Annika Maria Whittle^2*, Tony McVerry^2*, Maria Gilleece^2* and Inderjeet Dokal¹

¹Centre for Paediatrics, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
²Leeds Institute of Oncology, Leeds, United Kingdom
³Central Pathology Laboratory, University Hospital of North Staffordshire, Stoke-on-Trent, United Kingdom
⁴Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany

Rebecca D Ganetzky, B.A.^1*, Ying Jiang, M.D., Ph.D.^2*, Courtney Prince, B.S.^3*, Mikkael A. Sekeres, MD, MS⁴, Yogen Saunthararajah, M.D.³ and Jaroslaw P. Maciejewski, MD, PhD⁵

¹Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland Clinic, Cleveland, OH
²Hematologic Oncology and Blood Disorders/Experimental Hematology and Hematopoiesis Section, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
³Experimental Hematology and Hematopoiesis Section, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH
⁴Hematologic Oncology and Blood Disorders, Cleveland Clinic, Cleveland, OH
⁵Experimental Hematology and Hematopoiesis Section, Taussig Cancer Center, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Hideki Makishima, MD, PhD¹, Andrew J Dunbar^1*, Anna M Jankowska^1*, Lukasz P. Gondek, MD^1*, Eric D Hsi, MD², Michael A McDevitt, MD, PhD³, Alan F. List, MD, PhD^4* and Jaroslaw P. Maciejewski, MD, PhD⁵

¹Exp. Hem. & Hematopoiesis, Taussig Cancer Center, Cleveland, OH
²Clinical Pathology, Cleveland Clinic, Cleveland, OH
³Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD
⁴Risk Assessment, Detectio and Intervention Program, Moffitt Cancer Center, Tampa, FL
⁵Experimental Hematology and Hematopoiesis Section, Taussig Cancer Center, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Arati Khanna-Gupta, PhD¹, Hong Sun^1*, Jian Chen^1*, Stephanie Halene, MD², Paolo Sportoletti, MD^3*, Pier Paolo Pandolfi, MD, PhD^3* and Nancy Berliner^1*

¹Brigham and Women's Hospital, Boston, MA
²Yale Univ. School of Med., New Haven, CT
³Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

Daniel T. Starczynowski, PhD¹, Florian Kuchenbauer, MD^2*, Bob Argiropoulos, PhD^2*, Sandy Sung^1*, Ryan Morin, PhD^3*, Andrew L Muranyi, MSc^4*, Martin Hirst, PhD^3*, Donna E. Hogge, MD, PhD⁵, Marco Marra, PhD⁶, Richard A. Wells, MD, DPhil⁷, Wan Lam, PhD^8*, R. Keith Humphries, MD, PhD⁹ and Aly Karsan, MD¹⁰

¹Dept. of Medical Biophysics, BC Cancer Research Ctr., Vancouver, BC, Canada
²Terry Fox Laboratory, BC Cancer Research Agency, Vancouver, BC, Canada
³Genome Sciences Centre, BC Cancer Research Centre, Vancouver, BC, Canada
⁴Terry Fox Laboratory, BC Cancer Agency, Vancouver, BC, Canada
⁵B.C. Cancer Research Center, Vancouver, BC, Canada
⁶Genome Sciences Center, British Columbia Cancer Agency, Vancouver, BC, Canada
⁷Sunnybrook Health Sciences Centre, Toronto, ON, Canada
⁸Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada
⁹Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada
¹⁰British Columbia Cancer Rsch. Ctr., Vancouver, BC, Canada

Davendra P. Sohal^1*, Andrea Pellagati^2*, Li Zhou^1*, Yongkai Mo¹, Joanna B. Opalinska¹, Christina Alencar^1*, Christoph Heuck^1*, Amittha Wickrema³, Ellen Friedman^4*, John Greally^1*, Benjamin L. Ebert^5*, Jonathan Warner^1*, Jacqueline Boultwood² and Amit Verma¹

¹Albert Einstein College of Medicine, Bronx, NY
²John Radcliffe Hospital, United Kingdom
³University of Chicago, Chicago, IL
⁴Montefiore Med. Center, Bronx, NY
⁵Brigham and Women's Hospital, Boston, MA

Sanada Masashi, MD^1*, Shih Lee Yung, MD, PhD^2*, Takahiro Suzuki, MD, PhD^3*, Motohiro Kato, MD^1*, Mamiko Yanagimoto Sakata, MD, PhD^4*, Keiki Kumano, MD, PhD^5*, Norihiko Kawamata, MD, PhD^6*, Junko Takita, MD, PhD^5*, Hiraku Mori, MD, PhD^7*, Mineo Kurokawa, MD, PhD⁸, Shigeru Chiba, MD, PhD^9*, Mitsuhiro Omine, MD, PhD^7*, H. Phillip Koeffler, MD, PhD⁶ and Seishi Ogawa, MD, PhD¹

¹Cancer Genomics Project, University of Tokyo Hospital, Tokyo, Japan
²Department of Hematology/Oncology, Chungun Memorial Hospital, Taoyuan, Taiwan
³Division of Hematology, Department of Medicine, Jichi Medical University, Shimotsukeshi, Japan
⁴University of Tokyo Hospital, Tokyo, Japan
⁵Department of Cell Therapy & Transplantation Medicine, University of Tokyo Hospital, Tokyo, Japan
⁶Division of Hematology and Oncology, Cedars Sinai Medical Center, Los Angeles, CA
⁷Showa University Fujigaoka Hospital, Yokohama, Japan
⁸Department of Hematology and Oncology, Graduate School of Med., Tokyo, Japan
⁹Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan